MedPath

The effect of melatonin on circadian rest-activity rhythms

Phase 3
Conditions
Bipolar disorder.
Bipolar disorder
Registration Number
IRCT20200913048705N1
Lead Sponsor
Zahedan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
66
Inclusion Criteria

18 years or above
Had a diagnosis of bipolar mood disorder based on DSM-5
Were treated with at least one antipsychotic drug and had a daily use of at least one benzodiazepine drug for a minimum of 3 months

Exclusion Criteria

Present with current violent or aggressive behavior
Diagnosed with mental retardation, pervasive developmental disorder, dementia,
Physical diseases including hepatic impairment, terminal illness, severe somatic comorbidity, or epilepsy
Allergic to any compounds in the study medication
Fertile women
Breastfeeding women
Lack of informed consent
Comorbid mental disorders
Use of opioids and other drugs

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Circadian rest-activity rhythms. Timepoint: In days one, two and three. Method of measurement: Actigraph.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath